Zoetis Inc. operates in the animal health sector, offering a wide range of products for both livestock and companion animals. The company's history, strong product line, and strategic positioning in the healthcare industry make it a solid investment. However, the volatility of the market and competitive pressures require careful consideration.
The latest fundamental analysis provides a rating based on various financial metrics. Zoetis Inc. demonstrates strong return ratios but faces challenges in debt management and valuation metrics.
Category | Score | Visual |
---|---|---|
Discounted Cash Flow | 4 | |
Return on Equity | 5 | |
Return on Assets | 5 | |
Debt to Equity | 1 | |
Price to Earnings | 2 | |
Price to Book | 1 |
An overview of Zoetis Inc.'s historical performance against key financial metrics.
Date | Overall | DCF | ROE | ROA | Debt to Equity | P/E | P/B |
---|---|---|---|---|---|---|---|
2025-07-16 | 3 | 4 | 5 | 5 | 1 | 2 | 1 |
N/A | 0 | 4 | 5 | 5 | 1 | 2 | 1 |
Current analyst price targets offer insights into Zoetis Inc.'s potential stock performance.
High | Low | Median | Consensus |
---|---|---|---|
$243 | $160 | $170 | $191 |
Analysis of analyst sentiment underscores Zoetis Inc.'s market potential according to expert recommendations.
Recommendation | Count | Visual |
---|---|---|
Strong Buy | 1 | |
Buy | 16 | |
Hold | 12 | |
Sell | 0 | |
Strong Sell | 0 |
Zoetis Inc., a leader in animal health, shows robust returns on equity and assets, which are buoyed by its expansive product lineup. Analyst targets present a positive outlook, highlighting potential growth. While the stock demonstrates buy signals, potential risks include market volatility and debt challenges. As always, an investor should weigh these factors within the broader market context. The company's strategic focus on innovation may offer further opportunities in the rapidly advancing healthcare sector.